What is OraSure Technologies Return-on-Tangible-Asset?
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. OraSure Technologies's annualizedNet Income for the quarter that ended in Dec. 2023 was $80.3 Mil. OraSure Technologies's average total tangible assets for the quarter that ended in Dec. 2023 was $432.8 Mil. Therefore, OraSure Technologies's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 was 18.55%.
The historical rank and industry rank for OraSure Technologies's Return-on-Tangible-Asset or its related term are showing as below:
OSUR'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -5.73 Med: 5.47 Max: 13.86
Current: 12.88
During the past 13 years, OraSure Technologies's highest Return-on-Tangible-Asset was 13.86%. The lowest was -5.73%. And the median was 5.47%.
OSUR's Return-on-Tangible-Asset is ranked better than 89.83% of 865
companies
in the Medical Devices & Instruments industry
Industry Median: -2.38
vs OSUR: 12.88
OraSure Technologies Return-on-Tangible-Asset Historical Data
The historical data trend for OraSure Technologies's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of OraSure Technologies's Return-on-Tangible-Asset
For the Medical Instruments & Supplies subindustry, OraSure Technologies's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OraSure Technologies's Return-on-Tangible-Asset Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, OraSure Technologies's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where OraSure Technologies's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Dec. 2023) net income data.
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
OraSure Technologies Return-on-Tangible-Asset Related Terms
Thank you for viewing the detailed overview of OraSure Technologies's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
OraSure Technologies (OraSure Technologies) Business Description
OraSure Technologies is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets most of its sales from the molecular solutions business, derived mainly from customers in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OSUR has been successfully added to your 